Printer Friendly

Hong Kong Hospitals Get New Tool for the Fight Against SARS; Specialized Air Cleaners to Be Used to Take Virus Out of the Air.

SANTE FE SPRINGS, Calif., Oct. 16 /PRNewswire/ -- IQAir North America announced today that the Hong Kong Hospital Authority (HKHA) has selected IQAir's advanced air filtration systems as a new tool for combating the SARS virus. According to the World Health Organization (WHO) and the Centers for Disease Control (CDC) the most effective strategy in preventing another major SARS outbreak will be finding ways to limit transmission of the disease. The HKHA's selection of IQAir marks the first time specialized room air cleaners will be used as a control measure against SARS.

Much like the common flu, SARS is spread by close contact. When a person with SARS coughs or sneezes, or even during normal breathing, they contaminate the surrounding air with tiny droplets of infected matter. Someone in close proximity of the infected person can then become infected by breathing the contaminated air. According to the CDC, "It is possible that SARS can also spread more broadly through the air." Since there is no specific antiviral treatment for SARS, the most effective strategy is containment. While it is the WHO's first objective to prevent the international spread of this deadly disease, local health care institutions have begun looking for infection control measures that will help prevent further infections inside the hospitals themselves.

The HKHA currently manages 43 public hospitals, 47 specialist outpatient clinics and 13 general outpatient clinics in Hong Kong. The region was one of the worst affected areas in last winter's SARS epidemic with 1755 reported SARS cases (376 of which concerned healthcare workers), resulting in a total of 300 deaths.

"Nearly one fourth of all SARS infections in last winter's epidemic involved healthcare workers," said Robert Wiltbank, Vice President of Medical Air Solutions, a company that advises hospitals on infection control measures. "The risk of the disease being transmitted to other patients or healthcare workers is a major worldwide concern."

The HKHA focused on special engineering controls as part of their strategy in the fight against SARS. In order to find the most effective and reliable solution the Electrical and Mechanical Services Department (EMSD) of the Hong Kong Government performed rigorous tests on induct HVAC systems and room air cleaners. With the help of sophisticated laser particle counters that record the number of particles in the air, even those down below the size of a virus, the EMSD tested the actual filtration efficiency of numerous air filtration systems. After weeks of testing and the installation of several trial systems the HKHA finally chose IQAir as the only room air cleaner for SARS patients' rooms.

In the event that SARS is suspected in a patient, the HKHA will place a self contained mobile air cleaning system next to the patient's bed in Hong Kong hospitals. A flexible suction arm attached to the machine will be positioned near the patient's face to capture airborne droplets that are expelled by coughing and sneezing. The contaminated air is then drawn into the system and filtered in a 4-stage filtration process. At the final filtration stage the air cleaning system will remove even the tiniest airborne particulates, including the SARS virus, from the air. As a result the risk of infection within the patient's room can be greatly reduced, thus providing a safer working environment for healthcare personnel and reducing the possibility of spreading of the disease.

"This is true prevention," says Frank Hammes, President of IQAir North America. "Hong Kong is breaking new ground in infection control."

IQAir North America, Inc. is a member of the Swiss-based IQAir Group that develops, manufactures and markets innovative air quality products for indoor environments. IQAir products are used worldwide by hospitals and other critical environments. They also manufacture home air cleaning units for allergy and asthma sufferers and individuals with chemical sensitivities.
 IQAir is a registered trademark of the IQAir Group.

 For media inquiries, contact:

 Kirk Sullivan, APR
 IQAir North America, Inc.
 ksullivan@iqair.com
 (562) 903-7600 ext. 110
 (562) 318-4776 (cell)



CONTACT: media, Kirk Sullivan, APR of IQAir North America, Inc., +1-562-903-7600 ext. 110, or cell, +1-562-318-4776, ksullivan@iqair.com

Web site: http://www.iqair.com/
COPYRIGHT 2003 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 16, 2003
Words:683
Previous Article:Dex Media and CWA Settle on Terms of New Contract; Tentative Agreement Announced After All-Night Negotiations.
Next Article:University of St. Gallen's Media-MBA to Meet Prominent U.S. Business Leaders.
Topics:


Related Articles
500,000 SARS Masks Reach Hong Kong in Urgent Air Shipment by BAX Global; Joint Logistics Effort Between BAX Global and O'Mara Products Meets Critical...
LEAD: SARS in H.K. blocks due to 'unfortunate' run of events.
H.K. reports no new cases, hopes to get off SARS list soon.
ADALTIS announces positive results of the first clinical validation study of a New ELISA Kit (Detect-SARS), for the detection of antibodies to the...
ADALTIS Announces Positive Results of the First Clinical Validation Study of a New ELISA Kit (Detect-SARS(TM)), For the Detection of Antibodies to...
IQAir Files Complaint With FTC Against Consumer Reports Magazine; Watch Dog Agency May Be Doing Consumers More Harm Than Good.
H.K. steps up measures after China's SARS case confirmed.
New Research Could Lead to Potential Treatment for Avian Flu; Head Researcher Available for Comment on Hong Kong Influenza Research, SARS, Avian Flu...

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters